TipRanks
Advertisement
Advertisement

PCRIVAN Stock Latest News

Clinical Evidence Highlights Opportunity in Ultrasound-Guided Neuraxial Anesthesia
Private CompaniesClinical Evidence Highlights Opportunity in Ultrasound-Guided Neuraxial Anesthesia
2M ago
RIVAN
RIVANNA Advances AI-Guided Imaging Platforms With New FDA Clearances, Q4 Launch Plans, and Innovation Award
PremiumPrivate Companies
RIVANNA Advances AI-Guided Imaging Platforms With New FDA Clearances, Q4 Launch Plans, and Innovation Award
3M ago
RIVAN
RIVANNA Showcases Accuro 3S as FDA-Cleared AI Neuraxial Anesthesia Platform
PremiumPrivate Companies
RIVANNA Showcases Accuro 3S as FDA-Cleared AI Neuraxial Anesthesia Platform
3M ago
RIVAN
RIVANNA Highlights Regulatory Progress and Q4 Market Entry Plans for AI-Guided Anesthesia System
PremiumPrivate Companies
RIVANNA Highlights Regulatory Progress and Q4 Market Entry Plans for AI-Guided Anesthesia System
3M ago
RIVAN
RIVANNA Highlights AI-Enabled Accuro 3S Platform and FDA Milestones in Neuraxial Anesthesia
PremiumPrivate Companies
RIVANNA Highlights AI-Enabled Accuro 3S Platform and FDA Milestones in Neuraxial Anesthesia
3M ago
RIVAN
RIVANNA Highlights AI-Guided Accuro 3S Platform and FDA Clearances in Neuraxial Anesthesia
PremiumPrivate CompaniesRIVANNA Highlights AI-Guided Accuro 3S Platform and FDA Clearances in Neuraxial Anesthesia
4M ago
RIVAN
RIVANNA Advances AI Imaging Platforms as CBIC Innovator of the Year
Premium
Private Companies
RIVANNA Advances AI Imaging Platforms as CBIC Innovator of the Year
4M ago
RIVAN
Innovation Award Underscores RIVANNA’s Progress in Point-of-Care Medical Technology
Premium
Private Companies
Innovation Award Underscores RIVANNA’s Progress in Point-of-Care Medical Technology
4M ago
RIVAN
RIVANNA Recognition Underscores Commercial Progress in Point-of-Care Medtech
PremiumPrivate Companies
RIVANNA Recognition Underscores Commercial Progress in Point-of-Care Medtech
4M ago
RIVAN
RIVANNA Builds Momentum With FDA-Cleared Imaging Platforms, AI Expansion, and New Growth Programs
PremiumPrivate Companies
RIVANNA Builds Momentum With FDA-Cleared Imaging Platforms, AI Expansion, and New Growth Programs
4M ago
RIVAN
RIVANNA Gains Regional Recognition for Point-of-Care Imaging Innovation
PremiumPrivate Companies
RIVANNA Gains Regional Recognition for Point-of-Care Imaging Innovation
4M ago
RIVAN
RIVANNA Highlighted for Innovation in Clinical Decision-Support Imaging
PremiumPrivate Companies
RIVANNA Highlighted for Innovation in Clinical Decision-Support Imaging
4M ago
RIVAN
RIVANNA Highlights AI-Guided Anesthesia Platform and Expansion Cohort at DeviceTalks Boston
PremiumPrivate CompaniesRIVANNA Highlights AI-Guided Anesthesia Platform and Expansion Cohort at DeviceTalks Boston
4M ago
RIVAN
RIVANNA Showcases AI-Guided Accuro 3S and Launches Expansion Programs at DeviceTalks Boston
Premium
Private Companies
RIVANNA Showcases AI-Guided Accuro 3S and Launches Expansion Programs at DeviceTalks Boston
4M ago
RIVAN
RIVANNA Builds Momentum as Accuro XV Clearance Draws Trade Press and Investor Attention
Premium
Private Companies
RIVANNA Builds Momentum as Accuro XV Clearance Draws Trade Press and Investor Attention
4M ago
RIVAN
Media Coverage Builds Around RIVANNA’s Newly Cleared Accuro XV Imaging Platform
PremiumPrivate Companies
Media Coverage Builds Around RIVANNA’s Newly Cleared Accuro XV Imaging Platform
4M ago
RIVAN
RIVANNA’s Accuro XV Wins Trade Press Attention Following FDA 510(k) Clearance
PremiumPrivate Companies
RIVANNA’s Accuro XV Wins Trade Press Attention Following FDA 510(k) Clearance
4M ago
RIVAN
RIVANNA Highlights Regulatory Progress and Clinical Expansion in AI-Enabled MedTech
PremiumPrivate Companies
RIVANNA Highlights Regulatory Progress and Clinical Expansion in AI-Enabled MedTech
4M ago
RIVAN
RIVANNA Signals Regulatory and Clinical Momentum in AI-Driven MedTech
PremiumPrivate Companies
RIVANNA Signals Regulatory and Clinical Momentum in AI-Driven MedTech
4M ago
RIVAN
RIVANNA – Weekly Recap
PremiumPrivate CompaniesRIVANNA – Weekly Recap
4M ago
RIVAN
FDA Clearance Positions RIVANNA’s Accuro XV for Musculoskeletal Imaging Expansion
Premium
Private Companies
FDA Clearance Positions RIVANNA’s Accuro XV for Musculoskeletal Imaging Expansion
4M ago
RIVAN
RIVANNA Secures FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound
Premium
Private Companies
RIVANNA Secures FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound
4M ago
RIVAN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >